glp-1 alzheimer's 🧠 Researchers are exploring whether medications used for #diabetes and weight loss could treat #Alzheimers and addiction, but public concerns persist about long-term safety. 🔗 Read the full article at beingpatient.com # Neuroprotective Actions of Glucagon-Like Peptide-1

The average patient age was 75 years (range: 23 to 102 years)

Abstract The World Health Organization (WHO) has identified type 2 diabetes (T2DM) as a neglected, important, and re-emerging risk factor for tuberculosis (TB), especially in low and middle-income countries where TB is endemic

They are administered through small subcutaneous injections similar to insulin shots

Do not flush medications down the toilet or pour them into drains

Interleukin-2 concentration in hypothalamic structures of rats receiving peptides during mild stress

Stem cell niches may reactivate in cleared tissue Months 1-6+: Gradual tissue remodeling and functional recovery in organs where senescent cell burden was reduced This cascade explains why FOXO4-DRI doesn't produce immediate, obvious effects